SPAP

Acorai receives Breakthrough Device Designation for their non-invasive intracardiac pressure monitor

Retrieved on: 
Thursday, August 10, 2023
Heart failure, New Standard, HF, Intracardiac injection, SPAP, Patient, Machine learning, Motivation, External carotid artery, Ethics, System, FDA, Health, ICPM, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Breakthrough, Food, Software, Pharmaceutical industry, Medical device, Management, MD

Acorai is developing a first-of-its-kind, non-invasive intracardiac pressure monitoring (IPCM) device with a unique, patented hardware technology and proprietary machine learning system.

Key Points: 
  • Acorai is developing a first-of-its-kind, non-invasive intracardiac pressure monitoring (IPCM) device with a unique, patented hardware technology and proprietary machine learning system.
  • The Breakthrough Device application was supported by preliminary data of 281 patients from their 400-patient Swedish pilot study, which demonstrated a strong correlation to the invasive gold-standard measurements of pulmonary pressure.
  • Kasper Bourdette, Chief Operating Officer and Co-Founder added that "receiving breakthrough designation is a massive inflection point in our device development journey, and we are thrilled for the decision.
  • Implications of the Breakthrough Device Designation:
    Receiving the Breakthrough Device Designation accelerates the development and review process, underscoring the potential of Acorai to address unmet medical needs in heart failure management.

Acorai receives Breakthrough Device Designation for their non-invasive intracardiac pressure monitor

Retrieved on: 
Thursday, August 10, 2023
Heart failure, New Standard, HF, Intracardiac injection, SPAP, Patient, Machine learning, Motivation, External carotid artery, Ethics, System, FDA, Health, ICPM, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Breakthrough, Food, Software, Pharmaceutical industry, Medical device, Management, MD

Acorai is developing a first-of-its-kind, non-invasive intracardiac pressure monitoring (IPCM) device with a unique, patented hardware technology and proprietary machine learning system.

Key Points: 
  • Acorai is developing a first-of-its-kind, non-invasive intracardiac pressure monitoring (IPCM) device with a unique, patented hardware technology and proprietary machine learning system.
  • The Breakthrough Device application was supported by preliminary data of 281 patients from their 400-patient Swedish pilot study, which demonstrated a strong correlation to the invasive gold-standard measurements of pulmonary pressure.
  • Kasper Bourdette, Chief Operating Officer and Co-Founder added that "receiving breakthrough designation is a massive inflection point in our device development journey, and we are thrilled for the decision.
  • Implications of the Breakthrough Device Designation:
    Receiving the Breakthrough Device Designation accelerates the development and review process, underscoring the potential of Acorai to address unmet medical needs in heart failure management.

Senior Market Sales® Acquires New York-Based Field Marketing Organization CareValue

Retrieved on: 
Thursday, September 1, 2022
Partnership, National, Medicare Advantage, Technology, SMS, FMO, Insurance, Time, SPAP, Solution, Medigap, Organization, Creativity, Inc. (magazine), Risk management, Medicare, History, Long-term care, Risk, SEP, NMO, Acquisition, Growth, Industry, Health, Life, Health insurance, Mobile phone, Financial services, Bank, Alliant

OMAHA, Neb., Sept. 1, 2022 /PRNewswire/ -- Senior Market Sales® (SMS), one of the industry's premier insurance marketing organizations, has acquired CareValue, a rapidly growing national field marketing organization (FMO) based in Canandaigua, New York, and specializing in senior life and health insurance.

Key Points: 
  • OMAHA,Neb., Sept. 1, 2022 /PRNewswire/ -- Senior Market Sales (SMS), one of the industry's premier insurance marketing organizations, has acquired CareValue, a rapidly growing national field marketing organization (FMO) based in Canandaigua, New York, and specializing in senior life and health insurance.
  • Senior Market Sales(SMS) represents top Medicare Supplement, Medicare Advantage, annuity, life, long-term care, and travel insurance carriers in all 50 states.
  • CareValue offers a suite of technology solutions to support independent agents, agencies, National Marketing Organizations (NMO), and Field Marketing Organizations (FMO).
  • CareValue is actively engaging in contractual agreements in the Senior Insurance Market.

New York-Based Field Marketing Organization CareValue Acquired by Alliant with Senior Market Sales®

Retrieved on: 
Thursday, September 1, 2022
Partnership, National, Medicare Advantage, Technology, FMO, SMS, Insurance, Time, SPAP, Solution, Medigap, Organization, Creativity, Inc. (magazine), GLOBE, Risk management, Medicare, History, Summer, Long-term care, Risk, SEP, NMO, Acquisition, Growth, Industry, Health, Life, Health insurance, Mobile phone, Alliant

ROCHESTER, N.Y., Sept. 01, 2022 (GLOBE NEWSWIRE) -- CareValue, a rapidly growing national field marketing organization (FMO) based in Canandaigua, New York, and specializing in senior life and health insurance, has been acquired by Alliant with Senior Market Sales (SMS) one of the industry's premier insurance marketing organizations.

Key Points: 
  • ROCHESTER, N.Y., Sept. 01, 2022 (GLOBE NEWSWIRE) -- CareValue, a rapidly growing national field marketing organization (FMO) based in Canandaigua, New York, and specializing in senior life and health insurance, has been acquired by Alliant with Senior Market Sales (SMS) one of the industry's premier insurance marketing organizations.
  • Doyle has been in the insurance industry since 1996, hefounded CareValue in 2010, and since 2013 has partnered with SMS.
  • CareValue offers a suite of technology solutions to support independent agents, agencies, National Marketing Organizations (NMO), and Field Marketing Organizations (FMO).
  • Senior Market Sales (SMS) represents top Medicare Supplement, Medicare Advantage, annuity, life, long-term care, and travel insurance carriers in all 50 states.

Artia Solutions promotes Greg Kitchens, Matt Dull to co-CEO alongside George Kitchens

Retrieved on: 
Thursday, July 7, 2022
Review, Florida Medicaid waiver, Business, Solution, United States Senate Select Committee on Intelligence, Artia, DUR, Research, College, Legislation, Pharmacist, Partnership, PDL, P&T, ARTIA, CVS Caremark, AMCP, Doctor of Pharmacy, Environment, Technology, Florida State University, Calendar, Nursing, Samford University, SPAP, Smeal College of Business, State, Florida Senate, Physician, Hospital, Pharmaceutical industry, Medicine, Health insurance, Medicaid, Policy

TALLAHASSEE, Fla., July 7, 2022 /PRNewswire-PRWeb/ -- Artia Solutions is proud to announce the promotion of Greg Kitchens and Matt Dull to the role of co-CEO, alongside George Kitchens, who founded the company in 2005.

Key Points: 
  • Artia Solutions is proud to announce the promotion of Greg Kitchens and Matt Dull to the role of co-CEO, alongside George Kitchens, who founded the company in 2005.
  • TALLAHASSEE, Fla., July 7, 2022 /PRNewswire-PRWeb/ -- Artia Solutions is proud to announce the promotion of Greg Kitchens and Matt Dull to the role of co-CEO, alongside George Kitchens, who founded the company in 2005.
  • Greg Kitchens, PharmD, joined Artia in 2007, and he provides critical clinical resources and account management for our clients.
  • Resources managed by Greg include the ARTIA app, which is a custom P&T/DUR calendar mobile app, Artia Alerts emails, and the Artia Atlas client dashboard.